Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice

[Display omitted] Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of...

Full description

Saved in:
Bibliographic Details
Published inPharmacological research Vol. 158; p. 104878
Main Authors Chiricozzi, Andrea, Comberiati, Pasquale, D’Auria, Enza, Zuccotti, GianVincenzo, Peroni, Diego G.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.08.2020
Subjects
Atopic dermatitis
Children
Corticophobia
Corticosteroids
Pediatric
Side effects
Topical therapy
Side effects
Topical therapy
Corticosteroids
Atopic dermatitis
Children
Corticophobia
Pediatric
Online AccessGet full text

Cover

More Information
Summary:[Display omitted] Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations. Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1043-6618
1096-1186
DOI:10.1016/j.phrs.2020.104878